Eastern Kentucky University (EKU) received a Major Research Instrumentation (MRI) award of $381,870 from the National Science ...
Cells treated with ibrutinib and acalabrutinib each had a unique set of 13 m/z signals, which opens up the possibility of studying these metabolites as biomarkers of therapeutic response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback